Seres Therapeutics Reports Third Quarter Financial Results and Provides Business Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/7/2026

1. HUVR:IN
2. ANET
3. NKE
4. PANW
5. CL
6. SNDK
7. TAP
8. DELL
9. ROIV
10. BAC

Go back to Seres Therapeutics Reports Third Quarter Financial Results and Provides Business Update

Seres Therapeutics (MCRB) Tops Q3 EPS by 9c, Revenues Beat

November 5, 2019 7:39 AM EST

Seres Therapeutics (NASDAQ: MCRB) reported Q3 EPS of ($0.23), $0.09 better than the analyst estimate of ($0.32). Revenue for the quarter came in at $7.03 million versus the consensus estimate of $6.7 million.

Seres continues to advance our microbiome programs, and the Company is well resourced to reach important corporate... More